European Pharmaceutical Review

NOVEMBER 24, 2023

Amgen’s new immunotherapeutic agent Tarlatamab has been shown in a Phase II trial to provide sustained anti-tumour activity in 40 percent of the small cell lung cancer patients. The international DeLLphi-301study was investigated as a new anti-cancer treatment option for patients previously considered to be beyond treatment. Results from the trial were published in the New England Journal of Medicine.

Side effects 116

Side effects Patients Medicine Leads 116

Pharmaceutical Technology

NOVEMBER 24, 2023

Bayer announced the launch of a Berlin, Germany-based manufacturing facility to meet future demands from the US, China and Europe.

Manufacturing 105

Manufacturing 105

European Pharmaceutical Review

NOVEMBER 24, 2023

Novo Nordisk is investing over €2.1 billion (16 billion Danish kroner) to expand its production site in Chartres, France, supporting manufacture of its products for serious chronic diseases. Novo Nordisk’s multi-billion facility expansion This financial commitment will greatly strengthen manufacturing capacity, more than doubling the site’s footprint.

Manufacturing 98

Manufacturing Pharmaceutical manufacturing Pharmaceutical Medicine 98

PharmaTimes

NOVEMBER 24, 2023

Around 3,200 new cases of cervical cancer are diagnosed in the UK every year - News - PharmaTimes

105

105

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

European Pharmaceutical Review

NOVEMBER 24, 2023

The European Commission has granted a label expansion of the combination treatment KAFTRIO ® (ivacaftor/tezacaftor/elexacaftor) with ivacaftor, for children aged two to five years old with cystic fibrosis. The treatment from Vertex Pharmaceuticals is indicated for individuals who have at least one F508del mutation in the cystic fibrosis transmembrane conductance regulator ( CYSTIC FIBROSISTR ) gene.

Medicine 98

Medicine Pharmaceutical Patients Healthcare 98

PharmaTimes

NOVEMBER 24, 2023

The findings could benefit patients living with neurodegenerative conditions - News - PharmaTimes

Patients 99

Patients 99

pharmaphorum

NOVEMBER 24, 2023

International Health Partners' Christmas campaign: Working with pharma for patients worldwide Nicole.

Pharma 96

Pharma Patients 96

Pharmaceutical Technology

NOVEMBER 24, 2023

Vertex Pharmaceuticals has obtained approval from EC) for the label expansion of Kaftrio plus ivacaftor to treat children with CF.

Pharmaceutical 59

Pharmaceutical 59

Pharmacy Times

NOVEMBER 24, 2023

For pharmacists and pharmacy technicians, who work diligently to ensure our health and well-being, choosing the perfect holiday gift can be a thoughtful way to express gratitude and brighten their season.

59

59

Pharmaceutical Technology

NOVEMBER 24, 2023

The Sosei Heptares oral IBD drug was first licensed to GSK in 2020 and is currently in Phase I clinical development.

59

59

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

Pharmacy Times

NOVEMBER 24, 2023

In part 2 of this series, trauma-informed pharmacist Helen Sairany, PharmD, MBA, discusses the physical manifestations of burnout.

59

59

Pharmaceutical Technology

NOVEMBER 24, 2023

Access and buy GlobalData’s databook on the latest filings and grants activity for Johnson & Johnson here.

59

59

PharmaTech

NOVEMBER 24, 2023

Looking at the role that RSV and pediatric medical practices play in drug shortages.

Medical 52

Medical 52

Pharmaceutical Technology

NOVEMBER 24, 2023

Access and buy GlobalData’s databook on the latest filings and grants activity for F. Hoffmann-La Roche here.

59

59

Advertisement

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

Sales

Pharmaceutical Technology

NOVEMBER 24, 2023

Access and buy GlobalData’s databook on the latest filings and grants activity for Bristol-Myers Squibb here.

59

59

Pharmaceutical Technology

NOVEMBER 24, 2023

With more approved drugs coming through than ever before, the need to avoid confusing names to ensure patient safety is important.

Safety 52

Safety Patients 52

Pharmaceutical Technology

NOVEMBER 24, 2023

The expansion comes as Novo is trying to maintain strong growth in T2D after the launch of Eli Lilly’s Zepbound this month.

Manufacturing 52

Manufacturing 52

Pharmaceutical Technology

NOVEMBER 24, 2023

Access and buy GlobalData’s databook on the latest filings and grants activity for Novartis here.

59

59

Advertisement

Pharmaceutical Technology

NOVEMBER 24, 2023

China’s NMPA has approved ArkBio IND application for its respiratory syncytial virus (RSV) neutralising antibody, AK0610.

52

52

Pharmaceutical Technology

NOVEMBER 24, 2023

Ellipses Pharma has secured ODD from the US FDA for its next generation EP0031/A400, to potentially treat solid tumours.

FDA 52

FDA Pharma 52

Pharmaceutical Technology

NOVEMBER 24, 2023

Access and buy GlobalData’s databook on the latest filings and grants activity for Amgen here.

59

59

Pharmaceutical Technology

NOVEMBER 24, 2023

Lupin has introduced the fixed-dose triple combination drug (FDC), Vilfuro-G, to manage chronic COPD in India.

Management 52

Management 52

Advertisement

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

Sales

Pharmaceutical Technology

NOVEMBER 24, 2023

Epidiolex has been approved as an adjunct therapy for seizures associated with three rare forms of epilepsy in patients aged two and older.

Patients 131

Patients 131